Analysis of predictive scores for mortality after the first year of hospitalization for decompensated cirrhotic patients

Authors

DOI:

https://doi.org/10.33448/rsd-v10i16.23315

Keywords:

Decompensated cirrhosis; Mortality; Albumin; CLIF-SOFA.

Abstract

Patients with liver cirrhosis can progress to decompensation, reflecting in high mortality rates. Scores predictors of prognosis and mortality are useful tools in the management of patients with liver disease. The present study investigated the potential of scores and models to predict mortality after the first year of hospitalization in cirrhotic patients treated at a tertiary hospital in the Federal District, Brazil. This is a prospective cohort study that included adult individuals with liver cirrhosis, admitted for acute decompensation of cirrhosis, between November 2018 and May 2021. The criteria for the end of the prospection was one of the following outcomes: end of the period above, death or transplantation. Patients (male and female) with cirrhosis admitted at the hospital for more than one day for treatment of acute decompensation were included according to the previous criteria of the study. The following variables were analyzed: sex, age group, ethnicity, underlying cause of cirrhosis, reason for admission, presence of ascites, presence of encephalopathy, values ​​of biochemical tests on admission (creatinine, sodium, total bilirubin, INR, albumin) and severity of liver disease by CLIF-SOFA, MELD, MELD-Na and Child-Pugh scoring system models, measured in the admission to predict mortality after one year. Of the 115 patients with liver cirrhosis initially included, 63 were excluded for cancer during follow-up, therefore, 52 completed the study, 65% males. Alcoholic hepatitis was the main underlying cause of cirrhosis (46%), and intestinal bleeding was the main cause of hospitalization in decompensation (35%). Among the isolated biochemical parameters, only albumin on admission was significantly associated with the mortality outcome in one year. Among the models evaluated, the CLIF-SOFA showed a significant capacity as a predictor related to mortality in this period.

References

Bernardi, M., et al. (2020). Albumin in decompensated cirrhosis: new concepts and perspectives. Gut, 69, 1127.

Calmet, F., et al. (2019). Nutrition in patients with cirrhosis. Gastroenterology & Hepatology, 15, 248.

de Mattos, A. A., et al. (2003). Infecção bacteriana no paciente cirrótico. Arq Gastroenterol, 40, 11.

El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264.

Harrison, P. M. (2015). Management of patients with decompensated cirrhosis. Clinical Medicine, 15(2), 201.

Jalan, R., et al. (2014). Development and validation of a prognostic score to predict mortality in patients with acute-on- chronic liver failure. J Hepatol, 61. 1038-47.

Jeong, J. H., et al. (2016). CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis. Medicine, 95, 26.

Lida, V. H., et al. (2005). Cirrose hepática: aspectos morfológicos relacionados às suas possíveis complicações. J Bras Patol Med Lab, 41(1), 29.

Lima, E. N. S., et al. (2021). Serum albumin is independent predictor of hospital mortality in patients with cancer. Revista Brasileira de Cancerologia, 67(4), e-071209.

Mansour, D., & McPherson, S. (2018). Management of decompensated cirrhosis. Clinical Medicine, 18(2), s60.

Martins, F. L. (2013). Nutrição em paciente cirrótico. HU Revista, 39, 45.

Moreau, R., et al. (2013). Acute-on- chronic liver failure is a distinct syndrome developing in patients with acute decompensation of cirrhosis. Gastroenterology, 144, 1426- 37.

Samonakis, D. N., et al. (2014). Clinical outcomes of compensated and decompensated cirrhosis: A long term study. World J Hepatol, 6(7), 504.

Shah, N. L., et al. (2015). Management options in decompensated cirrhosis. Hepatic Medicine: Evidence and Research, 7, 43.

Trevisani, F., et al. (2007). Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Am J Gastroenterol; 102, 1022.

Toshikuni, N., et al. (2009). Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol, 24, 1276.

Xiao, Y., et al. (2021). High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence, 12(1), 1199.

Xu, X., et al. (2021). Risk stratification score to predict readmission of patients with acute decompensated cirrhosis within 90 days. Front Med, 8, 646875.

Wu, S-L., et al. (2018). Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy. World J Clin Cases, 6(15), 995.

Published

09/12/2021

How to Cite

AURELIANO, A. P. M. da S. .; SOARES, R. F. S. .; FARIAS, A. Q. de .; SILVA, F. N. A. .; CARNEIRO, M. de V.; CERDEIRA, C. D.; MENDES, L. S. C. . Analysis of predictive scores for mortality after the first year of hospitalization for decompensated cirrhotic patients. Research, Society and Development, [S. l.], v. 10, n. 16, p. e159101623315, 2021. DOI: 10.33448/rsd-v10i16.23315. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/23315. Acesso em: 25 nov. 2024.

Issue

Section

Health Sciences